Ali Musani
Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchoscopy | 45 | 2020 | 246 | 14.360 |
Why?
| Pulmonary Medicine | 15 | 2020 | 86 | 7.930 |
Why?
| Lung Neoplasms | 15 | 2020 | 2184 | 2.610 |
Why?
| Certification | 4 | 2020 | 110 | 2.460 |
Why?
| Lung Diseases | 7 | 2019 | 750 | 2.220 |
Why?
| Pleural Effusion, Malignant | 6 | 2017 | 16 | 2.100 |
Why?
| Pneumonectomy | 4 | 2020 | 122 | 1.980 |
Why?
| Photochemotherapy | 4 | 2020 | 30 | 1.790 |
Why?
| Pleural Diseases | 4 | 2019 | 22 | 1.600 |
Why?
| Endosonography | 6 | 2019 | 138 | 1.580 |
Why?
| Pulmonary Emphysema | 5 | 2020 | 315 | 1.400 |
Why?
| Airway Obstruction | 7 | 2015 | 161 | 1.390 |
Why?
| Societies, Medical | 6 | 2020 | 768 | 1.350 |
Why?
| Tracheal Stenosis | 5 | 2015 | 21 | 1.320 |
Why?
| Stents | 9 | 2016 | 386 | 1.250 |
Why?
| Tracheobronchomalacia | 2 | 2018 | 7 | 1.240 |
Why?
| Bronchi | 9 | 2018 | 242 | 1.210 |
Why?
| Tracheal Neoplasms | 2 | 2015 | 12 | 1.080 |
Why?
| Precancerous Conditions | 2 | 2015 | 166 | 1.060 |
Why?
| Pulmonologists | 2 | 2020 | 14 | 1.040 |
Why?
| Bronchial Diseases | 2 | 2013 | 37 | 1.040 |
Why?
| Physician's Role | 2 | 2019 | 221 | 0.990 |
Why?
| Tracheostomy | 4 | 2020 | 94 | 0.950 |
Why?
| Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 978 | 0.930 |
Why?
| Brachytherapy | 2 | 2020 | 100 | 0.890 |
Why?
| Rare Diseases | 2 | 2019 | 101 | 0.850 |
Why?
| Eligibility Determination | 1 | 2020 | 49 | 0.840 |
Why?
| Biopsy | 5 | 2019 | 1065 | 0.820 |
Why?
| Foreign Bodies | 2 | 2018 | 97 | 0.810 |
Why?
| Pleurodesis | 4 | 2013 | 7 | 0.800 |
Why?
| Humans | 71 | 2020 | 113846 | 0.800 |
Why?
| Thoracoscopy | 6 | 2019 | 53 | 0.780 |
Why?
| Clinical Competence | 5 | 2020 | 913 | 0.740 |
Why?
| Lung | 8 | 2019 | 3637 | 0.740 |
Why?
| Cryosurgery | 2 | 2019 | 57 | 0.740 |
Why?
| Pulmonary Disease, Chronic Obstructive | 4 | 2019 | 1224 | 0.740 |
Why?
| Dihematoporphyrin Ether | 1 | 2018 | 2 | 0.730 |
Why?
| Photosensitizing Agents | 2 | 2018 | 33 | 0.730 |
Why?
| Radiology, Interventional | 1 | 2018 | 25 | 0.720 |
Why?
| Ablation Techniques | 2 | 2019 | 26 | 0.720 |
Why?
| Optical Imaging | 2 | 2015 | 59 | 0.710 |
Why?
| Cough | 1 | 2018 | 96 | 0.690 |
Why?
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 34 | 0.680 |
Why?
| Bronchoscopes | 2 | 2013 | 6 | 0.680 |
Why?
| Tracheal Diseases | 2 | 2016 | 15 | 0.670 |
Why?
| Electromagnetic Phenomena | 2 | 2012 | 28 | 0.610 |
Why?
| Bronchial Neoplasms | 1 | 2015 | 15 | 0.600 |
Why?
| Bronchial Fistula | 1 | 2015 | 5 | 0.600 |
Why?
| Prostheses and Implants | 2 | 2014 | 157 | 0.600 |
Why?
| Precision Medicine | 1 | 2019 | 315 | 0.590 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 279 | 0.570 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 77 | 0.550 |
Why?
| Emphysema | 1 | 2014 | 108 | 0.530 |
Why?
| Tracheomalacia | 1 | 2012 | 14 | 0.500 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2013 | 138 | 0.500 |
Why?
| Light | 2 | 2015 | 385 | 0.490 |
Why?
| Lung Diseases, Interstitial | 1 | 2017 | 407 | 0.490 |
Why?
| Solitary Pulmonary Nodule | 2 | 2012 | 22 | 0.490 |
Why?
| Endoscopy | 1 | 2015 | 238 | 0.490 |
Why?
| Esophageal Neoplasms | 1 | 2015 | 222 | 0.490 |
Why?
| Carcinoid Tumor | 1 | 2012 | 21 | 0.480 |
Why?
| Paraganglioma | 1 | 2012 | 35 | 0.460 |
Why?
| Mass Screening | 1 | 2019 | 1055 | 0.450 |
Why?
| Adenocarcinoma | 1 | 2018 | 804 | 0.440 |
Why?
| Kidney Neoplasms | 1 | 2015 | 325 | 0.440 |
Why?
| Drainage | 4 | 2017 | 148 | 0.440 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 20 | 0.430 |
Why?
| Catheters, Indwelling | 4 | 2017 | 90 | 0.420 |
Why?
| Epithelial Cells | 2 | 2015 | 1032 | 0.400 |
Why?
| Colorectal Neoplasms | 1 | 2015 | 584 | 0.370 |
Why?
| Primary Health Care | 1 | 2019 | 1508 | 0.370 |
Why?
| Forced Expiratory Volume | 4 | 2020 | 545 | 0.360 |
Why?
| Correspondence as Topic | 1 | 2007 | 16 | 0.350 |
Why?
| Bereavement | 1 | 2007 | 46 | 0.340 |
Why?
| Tomography, X-Ray Computed | 8 | 2018 | 2380 | 0.340 |
Why?
| Betacoronavirus | 2 | 2020 | 265 | 0.330 |
Why?
| Treatment Outcome | 11 | 2020 | 9002 | 0.320 |
Why?
| Professional-Family Relations | 1 | 2007 | 136 | 0.310 |
Why?
| Sensitivity and Specificity | 3 | 2017 | 1930 | 0.300 |
Why?
| Mediastinal Neoplasms | 1 | 2005 | 41 | 0.300 |
Why?
| United States | 6 | 2020 | 12329 | 0.280 |
Why?
| Coronavirus Infections | 2 | 2020 | 339 | 0.280 |
Why?
| Pneumonia, Viral | 2 | 2020 | 354 | 0.280 |
Why?
| Educational Measurement | 2 | 2020 | 303 | 0.280 |
Why?
| Foreign-Body Migration | 2 | 2015 | 34 | 0.270 |
Why?
| Equipment Design | 4 | 2013 | 531 | 0.270 |
Why?
| Catheterization, Peripheral | 1 | 2004 | 86 | 0.270 |
Why?
| Catheterization | 2 | 2019 | 181 | 0.250 |
Why?
| Intubation, Intratracheal | 2 | 2016 | 202 | 0.250 |
Why?
| Diagnosis, Differential | 4 | 2012 | 1432 | 0.250 |
Why?
| Asthma | 7 | 2019 | 1933 | 0.250 |
Why?
| Electrocoagulation | 2 | 2013 | 35 | 0.250 |
Why?
| Neoplasm Staging | 3 | 2020 | 1226 | 0.240 |
Why?
| Pneumonia | 3 | 2019 | 558 | 0.230 |
Why?
| Immunohistochemistry | 2 | 2019 | 1831 | 0.230 |
Why?
| Biopsy, Needle | 2 | 2012 | 196 | 0.220 |
Why?
| Network Meta-Analysis | 1 | 2020 | 9 | 0.220 |
Why?
| Education, Medical, Graduate | 2 | 2017 | 385 | 0.220 |
Why?
| Mediastinum | 1 | 2020 | 20 | 0.210 |
Why?
| Inventions | 1 | 2020 | 17 | 0.210 |
Why?
| Pathologists | 1 | 2019 | 12 | 0.210 |
Why?
| Bronchoalveolar Lavage Fluid | 5 | 2008 | 655 | 0.200 |
Why?
| Bronchial Thermoplasty | 1 | 2019 | 1 | 0.200 |
Why?
| Education | 1 | 2020 | 110 | 0.200 |
Why?
| Thoracentesis | 1 | 2019 | 7 | 0.200 |
Why?
| Oncologists | 1 | 2019 | 29 | 0.200 |
Why?
| Male | 18 | 2017 | 60993 | 0.200 |
Why?
| Chronic Disease | 2 | 2018 | 1681 | 0.190 |
Why?
| Infection Control | 1 | 2020 | 135 | 0.190 |
Why?
| Specimen Handling | 1 | 2020 | 176 | 0.190 |
Why?
| Chest Tubes | 2 | 2009 | 27 | 0.190 |
Why?
| Image-Guided Biopsy | 1 | 2018 | 35 | 0.180 |
Why?
| Community-Acquired Infections | 1 | 2019 | 129 | 0.180 |
Why?
| Neoplasms | 2 | 2008 | 2037 | 0.180 |
Why?
| Female | 16 | 2017 | 63035 | 0.170 |
Why?
| Lung Volume Measurements | 2 | 2014 | 42 | 0.170 |
Why?
| Fellowships and Scholarships | 2 | 2017 | 210 | 0.160 |
Why?
| Accreditation | 1 | 2017 | 96 | 0.160 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 446 | 0.160 |
Why?
| Dogs | 1 | 2018 | 472 | 0.160 |
Why?
| Pandemics | 2 | 2020 | 881 | 0.160 |
Why?
| Logistic Models | 2 | 2012 | 2053 | 0.160 |
Why?
| Iatrogenic Disease | 1 | 2016 | 50 | 0.160 |
Why?
| Prognosis | 2 | 2019 | 3544 | 0.160 |
Why?
| Tumor Burden | 1 | 2017 | 281 | 0.150 |
Why?
| Radiography | 2 | 2012 | 828 | 0.150 |
Why?
| Absorbable Implants | 1 | 2015 | 40 | 0.150 |
Why?
| Narrow Band Imaging | 1 | 2015 | 14 | 0.150 |
Why?
| Ultrasonography | 1 | 2020 | 773 | 0.150 |
Why?
| Middle Aged | 11 | 2017 | 28753 | 0.150 |
Why?
| Intraoperative Complications | 1 | 2016 | 125 | 0.150 |
Why?
| Safety | 1 | 2017 | 319 | 0.150 |
Why?
| Recurrence | 4 | 2017 | 967 | 0.140 |
Why?
| Collagen Type III | 3 | 2004 | 30 | 0.140 |
Why?
| Bronchial Provocation Tests | 3 | 2004 | 50 | 0.140 |
Why?
| Aged | 7 | 2016 | 20109 | 0.140 |
Why?
| Trachea | 1 | 2016 | 229 | 0.140 |
Why?
| Fiber Optic Technology | 1 | 2013 | 21 | 0.140 |
Why?
| Retrospective Studies | 6 | 2016 | 11340 | 0.130 |
Why?
| Paracentesis | 1 | 2013 | 11 | 0.130 |
Why?
| Lung Transplantation | 2 | 2014 | 307 | 0.130 |
Why?
| Postoperative Complications | 2 | 2019 | 2116 | 0.130 |
Why?
| Device Removal | 2 | 2012 | 122 | 0.130 |
Why?
| Contraindications | 1 | 2013 | 97 | 0.130 |
Why?
| Cryotherapy | 1 | 2013 | 21 | 0.130 |
Why?
| Allergens | 3 | 2004 | 491 | 0.130 |
Why?
| Adult | 12 | 2015 | 31979 | 0.130 |
Why?
| Prosthesis Implantation | 1 | 2014 | 117 | 0.130 |
Why?
| Metals | 1 | 2014 | 124 | 0.120 |
Why?
| Glaucoma Drainage Implants | 1 | 2013 | 45 | 0.120 |
Why?
| Exercise Tolerance | 1 | 2014 | 234 | 0.120 |
Why?
| Gastroscopy | 1 | 2012 | 22 | 0.120 |
Why?
| Silicones | 1 | 2012 | 26 | 0.120 |
Why?
| Hemoptysis | 1 | 2012 | 29 | 0.120 |
Why?
| Laser Therapy | 1 | 2013 | 98 | 0.120 |
Why?
| Brain Abscess | 1 | 2012 | 10 | 0.120 |
Why?
| Pulmonary Alveolar Proteinosis | 1 | 2012 | 14 | 0.120 |
Why?
| Ultrasonography, Interventional | 1 | 2013 | 133 | 0.120 |
Why?
| Laryngoscopy | 1 | 2012 | 71 | 0.120 |
Why?
| Respiratory Sounds | 1 | 2012 | 98 | 0.110 |
Why?
| Debridement | 1 | 2011 | 89 | 0.110 |
Why?
| Genetic Therapy | 1 | 2013 | 277 | 0.110 |
Why?
| Lasers, Solid-State | 1 | 2011 | 24 | 0.110 |
Why?
| Pulmonary Surgical Procedures | 1 | 2011 | 8 | 0.110 |
Why?
| Respiratory Tract Fistula | 1 | 2011 | 7 | 0.110 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 137 | 0.110 |
Why?
| Curriculum | 1 | 2017 | 818 | 0.100 |
Why?
| Walking | 1 | 2014 | 383 | 0.100 |
Why?
| Recovery of Function | 1 | 2014 | 604 | 0.100 |
Why?
| Time Factors | 4 | 2017 | 7060 | 0.100 |
Why?
| Exercise Therapy | 1 | 2014 | 363 | 0.100 |
Why?
| Pneumothorax | 1 | 2009 | 35 | 0.100 |
Why?
| Bronchial Hyperreactivity | 1 | 2010 | 102 | 0.100 |
Why?
| Sclerotherapy | 1 | 2009 | 14 | 0.100 |
Why?
| Surveys and Questionnaires | 3 | 2020 | 4625 | 0.100 |
Why?
| Feasibility Studies | 1 | 2012 | 739 | 0.100 |
Why?
| Fibroblasts | 3 | 2004 | 906 | 0.100 |
Why?
| Image Processing, Computer-Assisted | 1 | 2013 | 725 | 0.090 |
Why?
| Pleural Cavity | 1 | 2008 | 2 | 0.090 |
Why?
| Follow-Up Studies | 3 | 2017 | 4906 | 0.090 |
Why?
| Seizures | 1 | 2012 | 339 | 0.090 |
Why?
| Pulmonary Surfactant-Associated Protein D | 1 | 2008 | 40 | 0.090 |
Why?
| Hypertension, Pulmonary | 1 | 2019 | 1669 | 0.090 |
Why?
| Pulmonary Alveoli | 1 | 2011 | 407 | 0.090 |
Why?
| Forms and Records Control | 1 | 2007 | 28 | 0.090 |
Why?
| Disease Models, Animal | 1 | 2018 | 3910 | 0.090 |
Why?
| Steroids | 1 | 2008 | 136 | 0.080 |
Why?
| Granulation Tissue | 1 | 2006 | 14 | 0.080 |
Why?
| Reimbursement Mechanisms | 1 | 2007 | 75 | 0.080 |
Why?
| Child | 2 | 2018 | 17711 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2012 | 6796 | 0.080 |
Why?
| Incidence | 1 | 2013 | 2470 | 0.080 |
Why?
| Empathy | 1 | 2007 | 125 | 0.080 |
Why?
| Patient Selection | 2 | 2020 | 694 | 0.080 |
Why?
| Thymus Neoplasms | 1 | 2005 | 21 | 0.080 |
Why?
| Thymoma | 1 | 2005 | 32 | 0.080 |
Why?
| Cytosine | 1 | 2006 | 50 | 0.080 |
Why?
| Muscle, Smooth | 2 | 2004 | 143 | 0.080 |
Why?
| Organophosphonates | 1 | 2006 | 100 | 0.070 |
Why?
| Pediatrics | 1 | 2013 | 1053 | 0.070 |
Why?
| Teratoma | 1 | 2005 | 101 | 0.070 |
Why?
| Lymphoma | 1 | 2005 | 180 | 0.070 |
Why?
| Actins | 2 | 2004 | 370 | 0.070 |
Why?
| Prospective Studies | 2 | 2013 | 6250 | 0.070 |
Why?
| Transforming Growth Factors | 1 | 2003 | 2 | 0.070 |
Why?
| Decision Support Techniques | 1 | 2007 | 388 | 0.060 |
Why?
| Interleukin-13 | 1 | 2004 | 134 | 0.060 |
Why?
| Eosinophils | 2 | 2002 | 269 | 0.060 |
Why?
| Smoking | 1 | 2012 | 1632 | 0.060 |
Why?
| Interleukin-4 | 1 | 2004 | 231 | 0.060 |
Why?
| Prosthesis Design | 2 | 2014 | 242 | 0.060 |
Why?
| Thyroid Neoplasms | 1 | 2005 | 249 | 0.060 |
Why?
| Risk Assessment | 1 | 2012 | 3147 | 0.060 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 173 | 0.060 |
Why?
| Myofibrils | 1 | 2002 | 49 | 0.060 |
Why?
| Algorithms | 1 | 2009 | 1558 | 0.060 |
Why?
| Transforming Growth Factor beta | 1 | 2004 | 468 | 0.050 |
Why?
| Ambulatory Care | 1 | 2004 | 461 | 0.050 |
Why?
| Plant Proteins | 1 | 2000 | 96 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 506 | 0.050 |
Why?
| Infant | 1 | 2013 | 8090 | 0.050 |
Why?
| Animals | 3 | 2018 | 35394 | 0.050 |
Why?
| Pollen | 1 | 2000 | 125 | 0.050 |
Why?
| Clinical Protocols | 1 | 2020 | 240 | 0.050 |
Why?
| Interleukin-10 | 1 | 2000 | 333 | 0.050 |
Why?
| Consensus | 1 | 2020 | 427 | 0.040 |
Why?
| Quality of Life | 3 | 2017 | 2136 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1251 | 0.040 |
Why?
| France | 1 | 2016 | 37 | 0.040 |
Why?
| Tracheoesophageal Fistula | 1 | 2016 | 29 | 0.040 |
Why?
| Single-Blind Method | 1 | 2017 | 280 | 0.040 |
Why?
| Airway Management | 1 | 2016 | 44 | 0.040 |
Why?
| Membrane Proteins | 1 | 2002 | 1098 | 0.040 |
Why?
| Cytokines | 1 | 2003 | 1981 | 0.030 |
Why?
| Faculty, Medical | 1 | 2017 | 244 | 0.030 |
Why?
| Oxygen | 2 | 2009 | 892 | 0.030 |
Why?
| Dilatation | 1 | 2014 | 53 | 0.030 |
Why?
| Constriction, Pathologic | 1 | 2014 | 176 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2014 | 2828 | 0.030 |
Why?
| Breast Neoplasms | 1 | 2004 | 1909 | 0.030 |
Why?
| Prosthesis Failure | 1 | 2014 | 118 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2017 | 602 | 0.030 |
Why?
| Risk Factors | 2 | 2019 | 9050 | 0.030 |
Why?
| Specialization | 1 | 2013 | 123 | 0.030 |
Why?
| Compassionate Use Trials | 1 | 2011 | 8 | 0.030 |
Why?
| Glucocorticoids | 2 | 2010 | 539 | 0.030 |
Why?
| Anti-Inflammatory Agents | 2 | 2008 | 460 | 0.030 |
Why?
| Blood Gas Analysis | 1 | 2009 | 88 | 0.030 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 1331 | 0.020 |
Why?
| Radiometry | 1 | 2008 | 47 | 0.020 |
Why?
| Critical Care | 1 | 2013 | 519 | 0.020 |
Why?
| Pulmonary Circulation | 1 | 2009 | 468 | 0.020 |
Why?
| Iridium Radioisotopes | 1 | 2006 | 5 | 0.020 |
Why?
| Immune System | 1 | 2008 | 198 | 0.020 |
Why?
| Exercise Test | 1 | 2009 | 598 | 0.020 |
Why?
| Medical Oncology | 1 | 2008 | 189 | 0.020 |
Why?
| Respiratory Tract Neoplasms | 1 | 2006 | 1 | 0.020 |
Why?
| Radiotherapy Dosage | 1 | 2006 | 252 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2008 | 649 | 0.020 |
Why?
| Papilloma | 1 | 2006 | 55 | 0.020 |
Why?
| Thoracic Neoplasms | 1 | 2006 | 35 | 0.020 |
Why?
| Apoptosis | 2 | 2008 | 2675 | 0.020 |
Why?
| Injections | 1 | 2006 | 164 | 0.020 |
Why?
| Pilot Projects | 1 | 2009 | 1421 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2010 | 1136 | 0.020 |
Why?
| Secondary Prevention | 1 | 2006 | 241 | 0.020 |
Why?
| Models, Statistical | 1 | 2008 | 693 | 0.020 |
Why?
| Cells, Cultured | 2 | 2004 | 4429 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 1009 | 0.020 |
Why?
| Tumor Necrosis Factor Decoy Receptors | 1 | 2002 | 14 | 0.020 |
Why?
| Immune Sera | 1 | 2002 | 81 | 0.020 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 39 | 0.020 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2002 | 68 | 0.020 |
Why?
| Solubility | 1 | 2002 | 275 | 0.010 |
Why?
| Bronchoalveolar Lavage | 1 | 2002 | 91 | 0.010 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2002 | 219 | 0.010 |
Why?
| Cohort Studies | 1 | 2011 | 5011 | 0.010 |
Why?
| Poaceae | 1 | 2000 | 74 | 0.010 |
Why?
| Antigens, Plant | 1 | 2000 | 70 | 0.010 |
Why?
| Analysis of Variance | 1 | 2004 | 1517 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 3049 | 0.010 |
Why?
| Cell Culture Techniques | 1 | 2002 | 364 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 909 | 0.010 |
Why?
| Cell Survival | 1 | 2002 | 1188 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 2229 | 0.010 |
Why?
| Dexamethasone | 1 | 2000 | 319 | 0.010 |
Why?
| Blotting, Western | 1 | 2002 | 1316 | 0.010 |
Why?
| Rats | 1 | 2008 | 6387 | 0.010 |
Why?
| Cell Movement | 1 | 2002 | 936 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2008 | 4275 | 0.010 |
Why?
| Kinetics | 1 | 2000 | 1800 | 0.010 |
Why?
| Case-Control Studies | 1 | 2004 | 3369 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 10971 | 0.010 |
Why?
| Macrophages | 1 | 2000 | 1343 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 18736 | 0.010 |
Why?
|
|
Musani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|